Ducommun Incorporated logo DCO - Ducommun Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $141.00 DETAILS
HIGH: $150.00
LOW: $132.00
MEDIAN: $141.00
CONSENSUS: $141.00
DOWNSIDE: 2.33%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Overvalued Strong
Trading 110.9% above fair value
Current Price $144.37
Bear Case $54.04 62.6% downside ($54.04 - $144.37) / $144.37 = -62.6% $2.33 × 18x + net cash
Fair Value $68.45 52.6% downside ($68.45 - $144.37) / $144.37 = -52.6% $2.33 × 22x + net cash
Bull Case $82.86 42.6% downside ($82.86 - $144.37) / $144.37 = -42.6% $2.33 × 26x + net cash

Adjust Assumptions

22.0x
2.33$

Key Value Driver

Through-cycle normalized EPS ($2.33)

Implied Market Multiple 62.0x

Plain-Language Summary

Our base-case estimate uses Normalized Earnings × Cycle Multiple. We then blend that result with the average analyst price target of $141.00 from 20 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $68.45 per share.

Warnings

This company has a built-in lending arm whose debt is mixed in with the main business. We capped the debt adjustment to avoid overstating what the core business owes.
Price-to-book value of 7.7x is above the normal range for this type of business (0.7x-2.0x). The stock may already price in a strong cycle.
Wall Street's average price target is $141.00 (from 20 analysts). Our estimate is 69% below the consensus -- consider that gap carefully.

Key Risks

  • Standard 10-year DCF produces unreliable terminal values for cyclicals
  • 'Cheap' P/E at cycle peak is the most common value trap — normalize first
  • Captive finance subsidiaries have different risk profiles from manufacturing